Healthcare

Report Name Published
Global Urinalysis Market By Product Type (Dipstick, Reagent, Analyzers, POC), Test Type (Biochemical, Sediment, Microscopic, Flow-Cytometric), Application (Diabetes, UTI, Kidney, Liver Disease, Pregnancy), End User (Hospitals, Diagnostic Labs) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Urinalysis Market was valued at USD 1.23 billion in 2016 and is projected to reach USD 2.37 billion by 2025, growing at a CAGR of 7.54% from 2017 to 2025. A urinalysis is used to detect and manage a wide range of disorders, such as urinary tract infections, kidney disease and diabetes. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing Prevalence of UTIs and Infections as well as kidney diseases 1.2 Implementation of stringent laws and regulations in the US for patient safety 1.3 Growing Technical assistance and developments 1.4 Growing geriatric population 1.5 Adoption of urinalysis devices 2. Market Restraints 2.1 Implementation of excise duty on medical devices 2.2 High costs Market Segmentation: 1. Global Urinalysis Market, by Application: 1.1 Disease Diagnosis 1.1.1 Urinary Tract Infections (UTI) 1.1.2 Kidney Diseases 1.1.3 Diabetes 1.1.4 Liver Diseases 1.1.5 Other Diseases 1.2 Pregnancy Tests 2. Global Urinalysis Market, by End User: 2.1 Hospitals & Clinics 2.2 Diagnostic Laboratories 2.3 Research Laboratories and Institutes 2.4 Home Care Settings 3. Global Urinalysis Market, by Product Type: 3.1 Consumables 3.1.1 Dipsticks 3.1.2 Reagents 3.1.3 Disposables 3.2 Instruments 3.2.1 Biochemical Urine Analyzers 3.2.1.1 Automated Biochemical Urine Analyzers 3.2.1.1.1 Low-Volume Automated Biochemical Urine Analyzers 3.2.1.1.2 Medium-Volume Automated Biochemical Urine Analyzers 3.2.1.1.3 High-Volume Automated Biochemical Urine Analyzers 3.2.1.2 Semi-Automated Biochemical Urine Analyzers 3.2.2 Automated Urine Sediment Analyzers 3.2.3 Point-Of-Care Devices 4. Global Urinalysis Market, by Test Type: 4.1 Biochemical Urinalysis 4.2 Sediment Urinalysis 4.2.1 Microscopic Urinalysis 4.2.2 Flow Cytometric Urinalysis 5. Global Urinalysis Market, by Region: 5.1 North America (U.S., Canada, Mexico) 5.2 Europe (Germany, UK, France, Rest of Europe) 5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 5.4 Latin America (Brazil, Argentina, Rest of Latin America) 5.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Siemens Healthcare (Subsidiary of Siemens AG) 2. Roche Diagnostics (A Division of F. Hoffmann-LA Roche Ltd.) 3. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) 4. Sysmex Corporation 5. Arkray, Inc. 6. Acon Laboratories, Inc. 7. Bio-Rad Laboratories, Inc. 8. 77 Elektronika Kft. 9. Mindray Medical International Limited 10. Urit Medical Electronic Group Co., Ltd. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Urinalysis Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Sepsis Diagnostics Market By Technology (Molecular Diagnostics, Microbiology, Immunoassay), Product (Instrument, Blood Culture Media), Method (Conventional & Automated), Usability (Laboratory & POC), Pathogen (Bacterial & Fungal) and Regional Market Size, Status and Forecast to 2025

Market Overview: The Global Sepsis Diagnostics Market was valued at USD 369.56 million in 2016 and is projected to reach USD 779.74 million by 2025, growing at a CAGR of 8.65% from 2017 to 2025. Sepsis is among the most common causes of death in hospitals. It arises from the host response to infection. Currently, diagnosis relies on nonspecific physiological criteria and culture-based pathogen detection. This problem is tackled by sepsis diagnostics where there is efficient detection and treatment of septic wounds, Thereby increasing the value of the market through medicinal benefits. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Prevalence of sepsis cases in neonatal and adult population 1.2 Growing demand of sepsis care in geriatric population 1.3 Increasing number of pre gestation period end births 1.4 High number of infections and hospital acquired infections 1.5 Increasing ratio of surgeries 1.6 High number pf pneumonia cases 1.7 Convenience provided by new technologies of curing and diagnosing sepsis 2. Market Restraints 2.1 High cost of devices 2.2 Reimbursement Issues Market Segmentation: 1. Global Sepsis Diagnostics Market, by Technology: 1.1 Microbiology 1.2 Molecular Diagnostics 1.3 Immunoassays 1.4 Flow Cytometry 2. Global Sepsis Diagnostics Market, by Product: 2.1 Instruments 2.2 Blood Culture Media 2.3 Assay Kits & Reagents 2.4 Software 3. Global Sepsis Diagnostics Market, by Usability: 3.1 Laboratory Testing 3.2 Point-Of-Care Testing 4. Global Sepsis Diagnostics Market, by Method: 4.1 Conventional Diagnostics 4.2 Automated Diagnostic 5. Global Sepsis Diagnostics Market, by Pathogen: 5.1 Bacterial Sepsis 5.1.1 Gram-Negative Bacterial Sepsis 5.1.2 Gram-Positive Bacterial Sepsis 5.2 Fungal Sepsis 5.3 Other Pathogen Infections 6. Global Sepsis Diagnostics Market, by Region: 6.1 North America (U.S., Canada, Mexico) 6.2 Europe (Germany, UK, France, Rest of Europe) 6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 6.4 Latin America (Brazil, Argentina, Rest of Latin America) 6.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Biomerieux SA 2. Becton, Dickinson and Company 3. Thermo Fisher Scientific Inc. 4. Abbott Laboratories, Inc. 5. Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.) 6. Cepheid Inc. 7. T2 Biosystems, Inc. 8. Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation) 9. Nanosphere, Inc. (A Luminex Company) 10. Bruker Corporation These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Sepsis Diagnostics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Respiratory Diagnostics Market By Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Respiratory Diagnostics Market was valued at USD 5.14 billion in 2016 and is projected to reach USD 9.35 billion by 2025, growing at a CAGR of 6.87% from 2017 to 2025. Respiratory Diagnostics is one of the most used technologies in medicinal sector and diagnosis centers. The reason of the market growth is mainly the lifestyle changes in young population and age related symptoms and diseases in geriatric population. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing Lung related diseases and infections 1.2 Changes in lifestyle and inclusion of smoking and tobacco consumption 1.3 Rise in geriatric population 1.4 Technological developments 2. Market Restraints 2.1 Risks associated with reimbursements 2.2 Rising Healthcare cost Market Segmentation: 1. Global Respiratory Diagnostics Market, by Test Type: 1.1 Mechanical Tests 1.1.1 Pulmonary Function Tests 1.1.1.1 Spirometry 1.1.1.2 Peak Flow Test 1.2 OSA Diagnostic Tests 1.3 Other Test Types 1.4 Imaging Tests 1.4.1 X-Ray 1.4.2 Computed Tomography 1.4.3 Magnetic Resonance Imaging (MRI) 1.4.4 Positron Emission Tomography (PET) 1.4.5 Other Imaging Tests 1.5 Traditional Diagnostic Tests 1.5.1 Immunodiagnostics 1.5.2 Biochemical Characterization 1.5.3 Microscopy 1.6 Molecular Diagnostic Tests 1.7 Pcr 1.7.1 Nucleic Acid Amplification Test 1.7.2 In Situ Hybridization 1.7.3 DNA Sequencing & Next-Generation Sequencing (NGS) 1.7.4 Microarrays 1.7.5 Other Molecular Diagnostic Tests 2. Global Respiratory Diagnostics Market, by Products and Services: 2.1 Instruments & Devices 2.2 Assays & Reagents 2.3 Services & Software 3. Global Respiratory Diagnostics Market, by End User: 3.1 Hospital/Clinical Laboratories 3.2 Reference Laboratories 3.3 Physician Offices 3.4 Other End Users 4. Global Respiratory Diagnostics Market, by Disease: 4.1 Tuberculosis 4.2 Asthma 4.3 Lung Cancer 4.4 Chronic Obstructive Pulmonary Disease 4.5 Other Respiratory Diseases 5. Global Respiratory Diagnostics Market, by Region: 5.1 North America (U.S., Canada, Mexico) 5.2 Europe (Germany, UK, France, Rest of Europe) 5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 5.4 Latin America (Brazil, Argentina, Rest of Latin America) 5.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Philips Healthcare 2. Becton, Dickinson & Company 3. Abbott Laboratories 4. Thermo Fisher Scientific Inc. 5. Biomérieux 6. Alere Inc. 7. Bio-Rad Laboratories, Inc. 8. Cosmed 9. Seegene Inc. 10. Sdi Diagnostic These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Respiratory Diagnostics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Molecular Diagnostics Market By Application (Infectious Disease (HIV, HBV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Hybridization, DNA Sequencing), End User (Hospitals, Laboratory), Product & Service (Reagent, Software) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Molecular Diagnostics Market was valued at USD 6.12 billion in 2016 and is projected to reach USD 12.93 billion by 2025, growing at a CAGR of 8.67% from 2017 to 2025. Molecular diagnostics is a combination of techniques used to analyze biological markers in the genome and proteome, genetic code and cells expression in terms of gene as proteins—by applying molecular biology to medical testing. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing oncology studies and cancer patients 1.2 Growing demand of personalized medicines 1.3 Growing Market of molecular biology and biomarker techniques in healthcare 1.4 Assured reimbursements 2. Market Restraints 2.1 Stringent regulations Market Segmentation: 1. Global Molecular Diagnostics Market, by Technology: 1.1 Polymerase Chain Reaction (PCR) 1.2 Isothermal Nucleic Acid Amplification Technology (INAAT) 1.3 Hybridization (In-Situ Hybridization & Fish) 1.4 DNA Sequencing and Next-Generation Sequencing 1.5 Microarray 1.6 Other Technologies 2. Global Molecular Diagnostics Market, by Application: 2.1 Infectious Diseases 2.1.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) 2.1.2 Hepatitis B 2.1.3 Human Papillomavirus (HPV) 2.1.4 Human Immunodeficiency Virus (HIV) 2.1.5 Tuberculosis (TB) 2.1.6 Hepatitis C 2.1.7 Methicillin-Resistant Staphylococcus Aureus (MRSA) 2.1.8 Other Infectious Diseases 2.2 Oncology 2.2.1 Breast Cancer 2.2.2 Colorectal Cancer 2.2.3 Prostate Cancer 2.2.4 Other Cancers 2.3 Blood Screening 2.4 Genetic Tests 2.5 Microbiology 2.6 Other Applications 3. Global Molecular Diagnostics Market, by End User: 3.1 Hospital and Academic Laboratories 3.2 Reference Laboratories 3.3 Other End Users 4. Global Molecular Diagnostics Market, by Products and Services: 4.1 Reagents & Kits 4.2 Instruments 4.3 Software & Services 5. Global Molecular Diagnostics Market, by Region: 5.1 North America (U.S., Canada, Mexico) 5.2 Europe (Germany, UK, France, Rest of Europe) 5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 5.4 Latin America (Brazil, Argentina, Rest of Latin America) 5.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Abbott Laboratories 2. Qiagen N.V. 3. Roche Diagnostics 4. Hologic, Inc. 5. Grifols 6. Siemens Healthcare 7. Becton, Dickinson and Company 8. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) 9. Biomérieux Sa 10. Cepheid Inc. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Molecular Diagnostics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Immunoassay Market By Product & Service (Reagents & Kits, Analyzers, Software, Services), Technique (ELISA, Rapid Test), Application (Infectious Diseases, Endocrinology, Oncology), End User (Clinical Labs, Hospitals) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Immunoassay Market was valued at USD 16.78 billion in 2016 and is projected to reach USD 32.88 billion by 2025, growing at a CAGR of 7.76% from 2017 to 2025. An immunoassay is a biochemical test that measures the presence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody or an antigen. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing cases of infections and chronic diseases 1.2 Increasing application of immunoassays in oncology studies and treatment 1.3 Technical progress 1.4 Growth in biotechnology and pharmaceutical R&D 2. Market Restraints 2.1 Low assurance of accuracy in results 2.2 Stringent Govt. regulations and Tax excision by US govt. on medical devices Market Segmentation: 1. Global Immunoassay Market, by Product and Services: 1.1 Reagents & Kits 1.2 By Type 1.2.1 Enzyme-Linked Immunosorbent Assay (ELISA) Reagents and Kits 1.2.2 Rapid Test Reagents and Kits 1.2.3 Western Blot Reagents and Kits 1.2.4 Elispot Reagents and Kits 1.2.5 RIA Reagents and Kits 1.2.6 PCR Reagents and Kits 1.3 Analyzers 1.3.1 Purchase Mode 1.3.1.1 Reagent Rental Purchase 1.3.1.2 Outright Purchase 1.3.2 By Type 1.3.2.1 Open-Ended Systems 1.3.2.2 Closed-Ended Systems 1.4 Software and Services 2. Global Immunoassay Market, by Technology: 2.1 Enzyme-Linked Immunosorbent Assay (ELISA) 2.1.1 ELISA Market, By Platform 2.1.1.1 Chemiluminescence Immunoassay (CLIA) 2.1.1.2 Fluorescence Immunoassay (FIA) 2.1.1.3 Colorimetric Immunoassay (CI) 2.1.2 ELISA Market, By Type 2.1.2.1 First Generation 2.1.2.2 Second Generation 2.1.2.3 Third Generation 2.1.2.4 Fourth Generation and Above 2.2 Rapid Tests 2.3 Western Blot 2.4 Elispot 2.5 Radioimmunoassay (RIA) 2.6 Polymerase Chain Reaction (PCR) 3. Global Immunoassay Market, by End User: 3.1 Hospitals 3.2 Clinical Laboratories 3.3 Blood Banks 3.4 Research & Academic Laboratories 3.5 Pharmaceutical Companies, Cros, and Biotechnology Companies 3.6 Other End Users 4. Global Immunoassay Market, by Application: 4.1 Infectious Diseases 4.2 Endocrinology 4.3 Bone and Mineral Disorders 4.4 Oncology 4.5 Cardiology 4.6 Hematology and Blood Screening 4.7 Autoimmune Disorders 4.8 Toxicology 4.9 Neonatal Screening 4.10 Other Applications 5. Global Immunoassay Market, by Region: 5.1 North America (U.S., Canada, Mexico) 5.2 Europe (Germany, UK, France, Rest of Europe) 5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 5.4 Latin America (Brazil, Argentina, Rest of Latin America) 5.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. F. Hoffmann-La Roche Ltd. 2. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) 3. Bio-Rad Laboratories, Inc. 4. Siemens AG 5. Sysmex Corporation 6. Biomerieux Sa 7. Alere Inc. 8. Becton, Dickinson and Company 9. Ortho Clinical Diagnostics, Inc. 10. Abbott Laboratories, Inc. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Immunoassay Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global HIV Diagnosis Market By Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global HIV Diagnosis Market was valued at USD 2.8 billion in 2016 and is projected to reach USD 6.66 billion by 2025, growing at a CAGR of 10.1% from 2017 to 2025. HIV tests are used to detect the presence of the human immunodeficiency virus, the virus that causes acquired immunodeficiency syndrome, in serum, saliva, or urine. Such tests may detect antibodies, antigens, or RNA. Increasing incidences of transfusing Unapproved or untested blood samples and other possible vector for HIV is causing the need of HIV diagnosis to rise. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing Patient count of HIV-AIDS 1.2 Growing incidences of blood transfusions and blood donation 1.3 Advantage of using Point-of-care kits 1.4 Increasing support from Govt. 2. Market Restraints 2.1 High cost 2.2 Lack of Regulations Market Segmentation: 1. Global HIV Diagnosis Market, by Test Type: 1.1 Antibody Tests 1.1.1 HIV-1 Screening Tests 1.1.1.1 Elisa 1.1.1.2 Rapid Tests 1.1.1.3 Home Access Dried Blood Spots 1.1.2 HIV-1 Antibody Confirmatory Tests 1.1.2.1 Western Blot Tests 1.1.2.2 Indirect Immunofluorescence Assays (IFA) 1.1.2.3 Line Immunoassays 1.1.2.4 Radio-Immunoprecipitation Assays 1.1.3 HIV-2 & Group O Diagnostic Tests 1.2 Viral Load Tests 1.3 CD4 Tests 1.4 Tests for Early Infant Diagnosis 1.5 Tests for Viral Identification 2. Global HIV Diagnosis Market, by Product: 2.1 Consumables 2.1.1 Assays and Kits & Reagents 2.1.2 Other Consumables 2.2 Instruments 2.3 Software & Services 3. Global HIV Diagnosis Market, by End User: 3.1 Diagnostic Laboratories 3.2 Hospitals 3.3 Blood Banks 3.4 Home Care Settings 3.5 Other End Users 4. Global HIV Diagnosis Market, by Region: 4.1 North America (U.S., Canada, Mexico) 4.2 Europe (Germany, UK, France, Rest of Europe) 4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 4.4 Latin America (Brazil, Argentina, Rest of Latin America) 4.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Siemens Healthineers (A Division of Siemens AG) 2. Roche Diagnostics (Division of Hoffman La Roche Ltd.) 3. Abbott Laboratories 4. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) 5. Thermo-Fisher Scientific Inc. 6. Merck KGaA 7. Becton, Dickinson & Company 8. Hologic Inc. 9. Alere Inc. 10. Bio-Rad Laboratories These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the HIV Diagnosis Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Coagulation/Hemostasis Analyzer Market By Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Coagulation/Hemostasis Analyzer Market was valued at USD 3.01 billion in 2016 and is projected to reach USD 9.69 billion by 2025, growing at a CAGR of 9.76% from 2017 to 2025. A good hemostasis analyzer (or coagulation analyzer) will provide either mechanical or optical clot detection – premium hemostasis analyzers can accomplish both. Multiple testing positions provide flexibility and versatility, and advanced proprietary mechanical testing methods have eliminated much of the uncertainty and assay repetition surrounding these important, critical tests of your patients' health. The reason for the market to grow is the efficiency of the devices and accuracy of the results (proven) in less time. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Growing diseases related to blood stream and cardiovascular functions 1.2 Growing Geriatric population 1.3 Efficiency of POC Coagulation testing method 1.4 Increasing advancements in technology and lab automation systems 2. Market Restraints 2.1 High equipment cost Market Segmentation: 1. Global Coagulation/Hemostasis Analyzer Market, by Test: 1.1 Prothrombin Time Testing 1.2 Fibrinogen Testing 1.3 Activated Clotting Time Testing 1.4 Activated Partial Thromboplastin Time Testing 1.5 D-Dimer Testing 1.6 Platelet Function Tests 1.7 Anti-Factor Xa Tests 1.8 Heparin & Protamine Dose Response Tests for ACT 2. Global Coagulation/Hemostasis Analyzer Market, By Product:: 2.1 Clinical Laboratory Analyzers 2.2 Consumables 2.3 Reagents 2.4 Standards, Controls, and Calibrations 2.5 Systems 2.6 Automated Systems 2.7 Semiautomated Systems 2.8 Manual Systems 2.9 Point-Of-Care Testing Analyzers 3. Global Coagulation/Hemostasis Analyzer Market, by Patient care Settings: 3.1 Clinical Laboratories 3.2 Point-Of-Care Testing 3.3 Other End Users 4. Global Coagulation/Hemostasis Analyzer Market, by Technology: 4.1 Optical Technology 4.2 Mechanical Technology 4.3 Electrochemical Technology 4.4 Other Technologies 5. Global Coagulation/Hemostasis Analyzer Market, by Region: 5.1 North America (U.S., Canada, Mexico) 5.2 Europe (Germany, UK, France, Rest of Europe) 5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 5.4 Latin America (Brazil, Argentina, Rest of Latin America) 5.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Alere Inc. 2. Nihon Kohden Corporation 3. Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.) 4. Siemens Healthcare (A Division of Siemens AG) 5. Sysmex Corporation 6. Thermo Fisher Scientific Inc. 7. Diagnostica Stago Sas 8. Helena Laboratories 9. Instrumentation Laboratory (A Division of the Werfen Group) 10. International Technidyne Corporation (ITC) These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Coagulation/Hemostasis Analyzer Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Blood Screening Market By Technology (Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assay, Next-Generation Sequencing), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Blood Screening Market was valued at USD 1.54 billion in 2016 and is projected to reach USD 3.63 billion by 2025, growing at a CAGR of 10% from 2017 to 2025. A blood screening is a medical process in which blood is scanned to test for a particular disease or condition. These processes vary according to the medical procedure to be performed. Increasing incidences of blood donation or transfusion is the key factor which is increasing the need of blood screening hence causing the market to grow rapidly. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing numbers of blood transfusions and donation cases 1.2 Increasing need of blood donation and transfusions 1.3 Growing number of infections 1.4 Safety awareness increment regarding blood donation 2. Market Restraints 2.1 Capital expenditure 2.2 Lack of regulations 2.3 Alternatives available Market Segmentation: 1. Global Blood Screening Market, by Product and Services: 1.1 Reagents & Kits 1.1.1 NAT Reagents & Kits 1.1.1.1 Enzymes and Polymerases 1.1.1.2 Standards and Controls 1.1.1.3 Probes and Primers 1.1.1.4 Buffers, Nucleotides and Solutions 1.1.1.5 Labeling and Detection Reagents 1.1.2 ELISA Reagents & Kits 1.1.2.1 Immunosorbents 1.1.2.2 Controls 1.1.2.3 Conjugates (Antigen Or Antibody-Conjugated Enzyme) 1.1.2.4 Substrates (Of Enzymes) 1.1.2.5 Sample Diluents and Wash Solutions 1.1.3 Other Reagents 1.2 Instruments 1.2.1 Rental Purchase 1.2.2 Outright Purchase 1.3 Software and Services 2. Global Blood Screening Market, by End User: 2.1 Blood Banks 2.2 Hospitals 3. Global Blood Screening Market, by Technology: 3.1 Nucleic Acid Test (NAT) 3.1.1 Transcription-Mediated Amplification (TMA) 3.1.2 Real-Time Polymerase Chain Reaction (PCR) 3.2 Enzyme-Linked Immunosorbent Assay (ELISA) 3.2.1 ELISA Market, By Platform 3.2.1.1 Chemiluminescence Immunoassay (CLIA) 3.2.1.2 Fluorescence Immunoassay (FIA) 3.2.1.3 Colorimetric Immunoassay (CI) 3.2.2 ELISA Market, By Generation 3.2.2.1 First-Generation ELISA 3.2.2.2 Second-Generation ELISA 3.2.2.3 Third-Generation ELISA 3.2.2.4 Fourth-Generation & Above 3.3 Rapid Tests 3.4 Western Blot Assay 3.5 Next-Generation Sequencing (NGS) 4. Global Blood Screening Market, by Region: 4.1 North America (U.S., Canada, Mexico) 4.2 Europe (Germany, UK, France, Rest of Europe) 4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 4.4 Latin America (Brazil, Argentina, Rest of Latin America) 4.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Grifols 2. F. Hoffmann-La Roche 3. Abbott Laboratories 4. Biomérieux 5. Bio-Rad Laboratories, Inc. 6. Siemens Healthineers (A Subsidiary of Siemens AG) 7. Ortho Clinical Diagnostics, Inc. 8. Thermo Fisher Scientific, Inc. 9. Beckman Coulter (A Subsidiary of Danaher Corporation) 10. Becton, Dickinson and Company These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Blood Screening Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Blood Group Typing Market By Product (Consumable (Anti-sera), Instrument, Service), Test Type (ABO, Antigen, Antibody Screening, Cross Matching, HLA), Technique (Assay, PCR, Microarray, Massively Parallel Sequencing), End User and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Blood Group Typing Market was valued at USD 1.67 billion in 2016 and is projected to reach USD 3.76 billion by 2025, growing at a CAGR of 9.44% from 2017 to 2025. Blood Typing is a very important part of medical procedures involving prenatal diagnostics, Transfusions and transplantations. The rising number of these processes in the healthcare field is the reason causing blood typing to grow. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing blood donation activities 1.2 Growing incidences of trauma, accidents and surgeries requiring blood transfusion 1.3 Growing demand of blood typing in prenatal testing 1.4 Growing importance of forensic studies and blood typing requirement in the forensic studies and examinations 1.5 Stringency towards careful blood transfusions 2. Market Restraints 2.1 High cost of equipment making it less accessible in developing nations Market Segmentation: 1. Global Blood Group Typing Market, by Technique: 1.1 PCR-Based and Microarray Techniques 1.2 Assay-Based Techniques 1.3 Massively Parallel Sequencing 1.4 Other Techniques 2. Global Blood Group Typing Market, by Products and Services: 2.1 Consumables 2.1.1 Antisera Reagents 2.1.2 Red Blood Cell Reagents 2.1.3 Anti-Human Globulin Reagents 2.1.4 Blood Bank Saline 2.2 Instruments 2.3 Services 3. Global Blood Group Typing Market, by End User: 3.1 Hospitals 3.2 Clinical Laboratories 3.3 Blood Banks 3.4 Other End Users 4. Global Blood Group Typing Market, by Test Type: 4.1 Antibody Screening 4.2 HLA Typing 4.3 ABO Blood Tests 4.4 Cross-Matching Tests 4.5 Antigen Typing 5. Global Blood Group Typing Market, by Region: 5.1 North America (U.S., Canada, Mexico) 5.2 Europe (Germany, UK, France, Rest of Europe) 5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 5.4 Latin America (Brazil, Argentina, Rest of Latin America) 5.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Bio-Rad Laboratories, Inc. 2. Beckman Coulter (A Subsidiary of Danaher) 3. Grifols International, S.A. 4. Immucor, Inc. 5. Merck KGaA 6. Novacyt Group 7. Quotient, Ltd. 8. Ortho Clinical Diagnostics, Inc. 9. Bag Health Care GmbH 10. Rapid Labs 11. AXO Science 12. Agena Bioscience, Inc. 13. Day Medical SA These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Blood Group Typing Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Anatomic Pathology Market By Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Anatomic Pathology Market was valued at USD 15.59 billion in 2016 and is projected to reach USD 25.61 billion by 2025, growing at a CAGR of 5.67% from 2017 to 2025. Anatomic pathology is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. With increasing prevalence of diseases and infections, major changes in lifestyle and pressure on Patient centric healthcare are major factors for the market to grow rapidly. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing cases of cancer 1.2 Growing geriatric population 1.3 Growing Healthcare investments 2. Market Restraints 2.1 Stringent Govt. Regulations like tax implementation n U.S. Market Segmentation: 1. Global Anatomic Pathology Market, by Application: 1.1 Diseases Diagnosis 1.2 Drug Discovery & Development 1.3 Other Applications 2. Global Anatomic Pathology Market, by Products & Services: 2.1 Instruments 2.1.1 Tissue Processing Systems 2.1.2 Slide Staining Systems 2.1.3 Microtomes 2.1.4 Other Instruments 2.2 Consumables 2.2.1 Antibodies & Reagents 2.2.2 Kits 2.2.3 Probes 2.2.4 Other Consumables 2.3 Services 2.3.1 Cytopathology 2.3.2 Histopathology 2.3.3 Other Services 3. Global Anatomic Pathology Market, by Region: 3.1 North America (U.S., Canada, Mexico) 3.2 Europe (Germany, UK, France, Rest of Europe) 3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 3.4 Latin America (Brazil, Argentina, Rest of Latin America) 3.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. F. Hoffmann-La Roche AG. 2. Danaher Corporation 3. Thermo Fisher Scientific, Inc. 4. Laboratory Corporation of America Holdings 5. Quest Diagnostics Incorporated 6. Agilent Technologies, Inc. 7. Sakura Finetechnical Co., Ltd. 8. Biogenex Laboratories 9. Bio SB 10. Neogenomics Laboratories, Inc. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Anatomic Pathology Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Atrial Fibrillation Surgery Market By Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) and Regional Market Size, Status and Forecast to 2025

Market Overview: The Global Atrial Fibrillation Surgery Market was valued at USD 1,026.99 million in 2016 and is projected to reach USD 3,797.26 million by 2025, growing at a CAGR of 13.97% from 2017 to 2025. The Atrial fibrillation surgery occurrence is becoming more frequent because of increasing geriatric population, also because of lifestyle changes in the young population. The efficiency of the surgeries is main factor considered to increase the growth of the market. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Rising occurrence of strokes, brain damage and atrial fibrillation owing to blood clots along with an increasing geriatric population 1.2 Technological advancements 1.3 Rising occurrence of diseases caused by lifestyle habits 1.4 Increasing demand for smaller cardiac incisions, minimally invasive procedures and small recovery time post-surgery 2. Market Restraints 2.1 High cost of healthcare Market Segmentation: 1. Global Atrial Fibrillation Surgery Market, by Procedure: 1.1 Catheter Ablation Procedures 1.2 Surgical Ablation/Maze Procedures 2. Global Atrial Fibrillation Surgery Market, by Product: 2.1 Catheter Ablation Product Market 2.2 Surgical Ablation Market 3. Global Atrial Fibrillation Surgery Market, by Region: 3.1 North America (U.S., Canada, Mexico) 3.2 Europe (Germany, UK, France, Rest of Europe) 3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 3.4 Latin America (Brazil, Argentina, Rest of Latin America) 3.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Biosense Webster, Inc. 2. Medtronic, Inc. 3. St. Jude Medical, Inc. 4. Boston Scientific Corporation 5. Atricure, Inc. 6. Cardiofocus, Inc. 7. Ncontact, Inc. 8. Carima, Inc. 9. Biotroik Se & Co.Kg These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Atrial Fibrillation Surgery Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Cardiac Marker Testing Market By Type (Troponin I & T, CK-MB, Myoglobin, BNP, hsCRP), Product (Reagent, Instrument), Method (Chemi-luminescence, ELISA), Disease (Myocardial Infarction, Congestive Heart Failure), Testing (Lab, POC) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Cardiac Marker Testing Market was valued at USD 2.11 billion in 2016 and is projected to reach USD 4.29 billion by 2025, growing at a CAGR of 8.21% from 2017 to 2025. Cardiac markers are biomarkers measured to evaluate heart function. They are often discussed in the context of myocardial infarction, but other conditions can lead to an elevation in cardiac marker level. The lifestyle changes in the young population and increase in Geriatric population is raising the need of better health solutions in cardiovascular disease care. The market is the primary focus for leading market players to increase the healthcare quality. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing cardiovascular Health issues min the population 1.2 Growing geriatric population all over the Globe 1.3 High fund gains from Govt. and Private players 1.4 Drives to discover novel cardiac markers through clinical Trials 2. Market Restraints 2.1 Issues in Sample collection, maintenance and storage 2.2 Reimbursement Issues Market Segmentation: 1. Global Cardiac Marker Testing Market, by Product: 1.1 Instruments 1.2 Reagents and Kits 1.2.1 Chemiluminescence 1.2.2 Immunofluorescence 1.2.3 Elisa 1.2.4 Immunochromatography 2. Global Cardiac Marker Testing Market, by Type: 2.1 Troponin I and T 2.2 CK-MB 2.3 Bnp Or Nt-Probnp 2.4 Myoglobin 2.5 Hscrp 2.6 Other Biomarkers 3. Global Cardiac Marker Testing Market, by Type Of Testing: 3.1 Laboratory Testing 3.2 Point-Of-Care Testing 4. Global Cardiac Marker Testing Market, by Disease: 4.1 Myocardial Infarction 4.2 Congestive Heart Failure 5. Global Cardiac Marker Testing Market, by Region: 5.1 North America (U.S., Canada, Mexico) 5.2 Europe (Germany, UK, France, Rest of Europe) 5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 5.4 Latin America (Brazil, Argentina, Rest of Latin America) 5.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Roche Diagnostics Limited (A Subsidiary of F. Hoffman-LA Roche Ltd.) 2. Abbott Laboratories 3. Siemens AG 4. Danaher Corporation 5. Biomérieux SA 6. Alere Inc. 7. LSI Medience Corporation (A Subsidiary 0f Mitsubishi Chemical Holdings Corporation) 8. Ortho Clinical Diagnostics (A Subsidiary of the Carlyle Group) 9. Randox Laboratories Ltd. 10. Guangzhou Wondfo Biotech Co., Ltd. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Cardiac Marker Testing Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Defibrillators Market By Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospital, Prehospital, Public Access, Home) and Regional Market Size, Status and Forecast to 2025

Market Overview: The Global Defibrillators Market was valued at USD 9.76 billion in 2016 and is projected to reach USD 17.76 billion by 2025, growing at a CAGR of 6.88% from 2017 to 2025. Atrial chokes and blockages is becoming a common problem for todays healthcare services. The key factor driving the market and pushing it to grow is the growth in geriatric population as well as lifestyle changes and habits. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Technological developments in the medical technology 1.2 Growing cases of cardiovascular diseases 1.3 Growing Geriatric population 1.4 Focus on making defibrillators more accessible 2. Market Restraints 2.1 Less awareness 2.2 Risks associated with External defibrillators 2.3 Stringent regulations in the U.S. Market Segmentation: 1. Global Defibrillators Market, by End User: 1.1 Hospitals, Clinics, & Cardiac Centers 1.2 Pre-Hospitals 1.3 Public Access Markets 1.4 Home Care 1.5 Alternate Care Markets 2. Global Defibrillators Market, by Product: 2.1 Implantable Cardioverter Defibrillators (ICDS) 2.1.1 Implantable Cardioverter Defibrillators (T-ICDS) 2.1.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS) 2.1.1.2 Dual-Chamber ICDS 2.1.1.3 Single-Chamber ICDS 2.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS) 2.2 External Defibrillators 2.2.1 Automated External Defibrillators (AEDS) 2.2.1.1 Semi-Automated External Defibrillators 2.2.1.2 Fully Automated External Defibrillators 2.3 Manual External Defibrillators 2.4 Wearable Cardioverter Defibrillators (WCDS) 3. Global Defibrillators Market, by Region: 3.1 North America (U.S., Canada, Mexico) 3.2 Europe (Germany, UK, France, Rest of Europe) 3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 3.4 Latin America (Brazil, Argentina, Rest of Latin America) 3.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Medtronic PLC 2. St. Jude Medical, Inc. 3. Boston Scientific Corporation 4. Philips Healthcare (A Division of Koninklijke Philips N.V.) 5. Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation) 6. Biotronik Se & Co.Kg 7. Physio-Control International, Inc. 8. Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group) 9. Sorin Group (Now Livanova PLC) 10. Nihon Kohden Corporation These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Defibrillators Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global ECG Cable and ECG Lead wires Market By Material (Thermoplastic Elastomer, TPU), Usability (Reusable, Disposable), ECG Lead wires by Machine Type (3 lead, 5 lead), Patient Care Setting (Long term care facilities, Home care) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global ECG Cable and ECG Lead wires Market was valued at USD 1.04 billion in 2016 and is projected to reach USD 1.65 billion by 2025, growing at a CAGR of 5.3% from 2017 to 2025. The growing healthcare concerns and treatment sector in medical market is the main driver of the ECG Cable and ECG Lead wires market. Market players are increasing focus quality of medical devices to keep pace in the competition. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing Geriatric Population 1.2 Growing number of cardiovascular failures and patients 1.3 Growing Technical support 1.4 Govt. Support is also increasing in favor of monitoring devices 2. Market Restraints 2.1 High cost of the devices 2.2 High cost of disposable cables Market Segmentation: 1. Global ECG Cable and ECG Lead wires Market, by Usability: 1.1 Reusable Cables and Lead wires 1.2 Disposable Cables and Lead wires 2. Global ECG Cable and ECG Lead wires Market, by Material: 2.1 TPE 2.2 TPU 2.3 Other Materials 3. Global ECG Cable and ECG Lead wires Market, by Patient Care Setting: 3.1 Hospitals 3.2 Long-Term Care Facilities 3.3 Clinics 3.4 Ambulatory and Home Care 4. Global ECG Cable and ECG Lead wires Market, by Machine Type: 4.1 12-Lead ECG Leadwires 4.2 5-Lead ECG Leadwires 4.3 3-Lead ECG Leadwires 4.4 6-Lead ECG Leadwires 4.5 Single-Lead ECG Leadwires 4.6 Other ECG Leadwires 5. Global ECG Cable and ECG Lead wires Market, by Region: 5.1 North America (U.S., Canada, Mexico) 5.2 Europe (Germany, UK, France, Rest of Europe) 5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 5.4 Latin America (Brazil, Argentina, Rest of Latin America) 5.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. 3M Company 2. Becton, Dickinson and Company 3. Medtronic Public Limited Company 4. Koninklijke Philips N.V. 5. Curbell Medical Products, Inc. 6. Welch Allyn, Inc. 7. Conmed Corporation 8. OSI Systems, Inc. 9. Schiller AG 10. Mindray Medical International Limited These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the ECG Cable and ECG Lead wires Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) and Regional Market Size, Status and Forecast to 2025

Market Overview: The Global Microbiology Testing/Clinical Microbiology Market was valued at USD 3.21 billion in 2016 and is projected to reach USD 8.19 billion by 2025, growing at a CAGR of 10.97% from 2017 to 2025. Microbiology is a wide scope of number of sub fields. Microbiology testing and Clinical microbiology focuses on pathogen testing and identification. The industry is rising in terms of market value because of increasing R&D Activities and Fund. There is now more focus on advanced medicinal solutions and vaccine production to avoid epidemic spreads. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Technological developments and Researches 1.2 Growing Number of infections, Epidemic Incidences and spreads 1.3 Growing Fund in the research and development sector by Govt. and private Sector 2. Market Restraints 2.1 Reimbursement risks 2.2 Lack of Regulatory restrictions Market Segmentation: 1. Global Microbiology Testing/Clinical Microbiology Market, by Application: 1.1 Pharmaceutical Applications 1.2 Clinical Applications 1.3 Food Testing Applications 1.4 Food Testing Applications 1.5 Energy Applications 1.6 Chemical and Material Manufacturing Applications 1.7 Environmental Applications 2. Global Microbiology Testing/Clinical Microbiology Market, by Disease Area: 2.1 Respiratory Diseases 2.2 Bloodstream Infections 2.3 Gastrointestinal Diseases 2.4 Sexually Transmitted Diseases 2.5 Urinary Tract Infections (UTIS) 2.6 Periodontal Diseases 2.7 Other Diseases 3. Global Microbiology Testing/Clinical Microbiology Market, by Product: 3.1 Reagents 3.1.1 Pathogen specific kits 3.1.2 General reagents 3.2 Instruments 3.2.1 Microbiology Analyzers 3.2.1.1 Molecular Diagnostic Instruments 3.2.1.2 Microscopes 3.2.1.3 Mass Spectrometers 3.2.2 Laboratory equipment 3.2.2.1 Incubators 3.2.2.2 Gram Stainers 3.2.2.3 Bacterial Colony Counters 3.2.2.4 Autoclave Sterilizers 3.2.2.5 Microbial Air Samplers 3.2.2.6 Anaerobic Culture Systems 3.2.2.7 Petri Dish Fillers 3.2.2.8 Blood Culture Systems 3.2.2.9 Microbial Culture Systems 3.2.2.10 Other Laboratory Instruments 4. Global Microbiology Testing/Clinical Microbiology Market, by Region: 4.1 North America (U.S., Canada, Mexico) 4.2 Europe (Germany, UK, France, Rest of Europe) 4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 4.4 Latin America (Brazil, Argentina, Rest of Latin America) 4.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Biomerieux S.A. 2. Danaher Corporation 3. Becton, Dickinson and Company 4. Cepheid (U.S.) 5. Abbott Laboratories, Inc. 6. Alere, Inc. 7. Bio-Rad Laboratories Inc. 8. F. Hoffman-LA Roche Ltd. 9. Bruker Corporation 10. Hologic, Inc. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Microbiology Testing/Clinical Microbiology Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global HLA Typing for Transplant Market By Technology ,SSO-PCR, SSP-PCR, NGS, Sangers Sequencing, Products and Services -Instruments, Reagents, Software, Application Diagnostics, Research, End User Hospitals, Academia, Diagnostic Center and Regional Market Size, Status and Forecast to 2025

Market Overview: The global HLA Typing for Transplant Market was valued at USD 533.78 million in 2016 and is projected to reach USD 970.65 million by 2025, growing at a CAGR of 6.87% from 2017 to 2025. Human leukocyte antigen (HLA) typing is used to match patients and donors for bone marrow or cord blood transplants. Due to increasing transplant failures there is a rising need to match the organ transplant feasibility before the surgery to avoid any kind of loss. There are increasing fund in the HLA Typing market from the side of Govt. as well as Pvt. Sector. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Growing number of Tissue and Organ transplantations 1.2 Growing technical support and discoveries in HLA Typing 1.3 Growing Funds from both Government and Private sector 2. Market Restraints 2.1 High technology associated costs 2.2 Limited reimbursements 2.3 High cost of techniques like PCR Market Segmentation: 1. Global HLA Typing for Transplant Market, by Applications: 1.1 Research applications 1.2 Diagnostic Applications 2. Global HLA Typing for Transplant Market, by Products and Services: 2.1 Reagents and Consumables 2.2 Software and Services 2.3 Instruments 3. Global HLA Typing for Transplant Market, by End User: 3.1 Commercial Service Providers 3.2 Research Laboratories and Academic Institutes 3.3 Hospitals and Transplant Centers 4. Global HLA Typing for Transplant Market, by Technology: 4.1 Non Molecular Assays 4.1.1 Mixed Lymphocyte Culture (MLC) Assays 4.1.2 Serological Assays 4.2 Molecular Assays 4.2.1 Sequencing Based 4.2.1.1 Next-Generation Sequencing (NGS) 4.2.1.2 Sanger Sequencing 4.2.2 PCR Based 4.2.2.1 Sequence-Specific Oligonucleotide (SSO)-PCR 4.2.2.2 Sequence-Specific Primer (SSP)-PCR 5. Global HLA Typing for Transplant Market, by Region: 5.1 North America (U.S., Canada, Mexico) 5.2 Europe (Germany, UK, France, Rest of Europe) 5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 5.4 Latin America (Brazil, Argentina, Rest of Latin America) 5.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Thermo Fisher Scientific, Inc. 2. Immucor, Inc. 3. Olerup SSP AB 4. Qiagen N.V. 5. Bio-Rad Laboratories, Inc. 6. Illumina, Inc. 7. Affymetrix, Inc. 8. F. Hoffmann-LA-Roche Limited 9. Luminex Corporation 10. Abbott Laboratories, Inc. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the HLA Typing for Transplant Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Dairy Herd Management Market By Product [Automated Systems (Milking Parlors, Meters, Sensors, Reproductive & Health, Cattle Management), Software (On-premise, Cloud-based)], Application (Feeding, Breeding), End user (Large Farms) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Dairy Herd Management Market was valued at USD 2.13 billion in 2016 and is projected to reach USD 3.66 billion by 2025, growing at a CAGR of 6.21% from 2017 to 2025. Dairy herd management software is the easy access to keep a track of animal population on the farm and their personalized details about insemination, Productivity and other dairy factors. The market is growing because of increasing dairy needs all over the globe and also because on increasing awareness amongst farm managers and owners regarding technological advancements which can enhance the marketing strategies to meet the competition. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing Dairy consumption rates 1.2 Growing number dairy projects and herd population 1.3 Growing Technological advancements 1.4 Cost cutting and economic benefits 1.5 Growing fund in Dairy and its efficiency increment projects 2. Market Restraints 2.1 Ethical issues for animal safety Market Segmentation: 1. Global Dairy Herd Management Market, by Application: 1.1 Milk Harvesting 1.2 Breeding 1.3 Feeding 1.4 Cow Comfort and Heat Stress Management 1.5 Calf Management 1.6 Health Management 1.7 Other Applications 2. Global Dairy Herd Management Market, by Product: 2.1 Standalone 2.1.1 On-Premise Software 2.1.2 Web-Based/Cloud-Based Software 2.2 Automated 2.2.1 Milk Management Systems 2.2.2 Feeding/Nutrition Management Systems 2.2.3 Reproductive Health Management Systems 2.2.4 Cattle Management Systems 2.2.5 Herd Health Management Systems 3. Global Dairy Herd Management Market, by End User: 3.1 Large-Scale Dairy Farms 3.2 Cooperative Dairy Farms 3.3 Small-Scale Dairy Farms 4. Global Dairy Herd Management Market, by Region: 4.1 North America (U.S., Canada, Mexico) 4.2 Europe (Germany, UK, France, Rest of Europe) 4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 4.4 Latin America (Brazil, Argentina, Rest of Latin America) 4.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Delaval 2. GEA 3. Afimilk 4. Boumatic 5. Fullwood 6. SCR 7. Dairymaster 8. Lely 9. VAS 10. Sum-IT Computer Systems 11. Pearson International 12. Farmwizard 13. Farmtec 14. Waikato Milking Systems 15. Trioliet These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Dairy Herd Management Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Blood Culture Tests Market By Method (Automated, Manual), Product (Consumables, Instrument), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Fungemia) & End User (Hospital Laboratories, Reference Laboratories) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Blood Culture Tests Marketwas valued at USD 3,251.63 million in 2016 and is projected to reach USD 6,254.92 million by 2025, growing at a CAGR of 7.54% from 2017 to 2025. Blood cultures are used to detect the presence of bacteria or fungi in the blood, to identify the type present, and to guide treatment. Testing is used to identify a blood infection (septicemia) that can lead to sepsis, a serious and life-threatening complication. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing cases of sepsis cases 1.2 GrowingGeriatric Population 1.3 Increasing research and product launches 1.4 Increasing incidences of Bloodstream infections 1.5 Demand for Rapid and Efficient diagnostics 1.6 High number of infections and disease spreads 2. Market Restraints 2.1 High cost of equipment 2.2 Lack of Trained technicians Market Segmentation: 1. Global Blood Culture Tests Market, by Application: 1.1 Bacteremia 1.2 Fungemia 1.3 Mycobacterial Detection 2. Global Blood Culture Tests Market, by Technology: 2.1 Proteomics Technology 2.2 Culture-Based Technology 3. Global Blood Culture Tests Market, by Method: 3.1 Conventional/Manual Methods 3.2 Automated Methods 3.3 Molecular Technologies 3.3.1 Microarrays 3.3.2 PCR (Polymerase Chain Reaction) 3.3.3 PNA-FiSH (Peptide Nucleic Acid – Fluroscent in Situ 4. Global Blood Culture Tests Market, byEnd User: 4.1 Hospital Laboratories 4.2 Reference Laboratories 4.3 Academic Research Laboratories 4.4 Other Laboratories 5. Global Blood Culture Tests Market, byProduct: 5.1 Consumables 5.1.1 Assay Kits & Reagents 5.1.2 Blood Culture Accessories 5.1.3 Blood culture Media 5.1.3.1 Aerobic Blood Culture Media 5.1.3.2 Pediatric Aerobic Blood Culture Media 5.1.3.3 Anaerobic Blood Culture Media 5.1.3.4 Mycobacterial Blood Culture Media 5.1.3.5 Fungi/Yeast Blood Culture Media 5.2 Instruments 5.2.1 Supporting Laboratory Equipment 5.2.1.1 Incubators 5.2.1.2 Colony Counters 5.2.1.3 Microscopes 5.2.1.4 Gram Stainers 5.2.2 Automated Blood Culture Systems 5.3 Software and Services 6. Global Blood Culture Tests Market, by Region: 6.1 North America (U.S., Canada, Mexico) 6.2 Europe (Germany, UK, France, Rest of Europe) 6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 6.4 Latin America (Brazil, Argentina, Rest of Latin America) 6.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Becton, Dickinson and Company 2. Biomérieux SA 3. Thermo Fisher Scientific, Inc. 4. Cepheid 5. Nanosphere, Inc. 6. Bruker Corporation 7. Beckman Coulter (Wholly Owned Subsidiary of Danaher Corporation) 8. Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.) 9. Iridica (A Subsidiary of Abbott Laboratories) 10. T2 Biosystems These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Blood Culture Tests Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global 3D Cell Culture Market By Product (Scaffold-free (Hanging Drop, Bioreactor), Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell Research, Drug Discovery), End User (Pharmaceutical, Biotech, Research) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global 3D Cell Culture Market was valued at USD 569.65 million in 2016 and is projected to reach USD 2,792.72 million by 2025, growing at a CAGR of 19.32% from 2017 to 2025. A 3D cell culture is an artificially created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. The reason of the market growth evident in the market values is the need to efficiently imitate the natural conditions in vitro to eliminate the animal testing and other methods of clinical testing. Additionally, there are govt. fund available for R&D to implement the respective technology. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increment in the risks related to animal testing and Stringent Govt. Regulations 1.2 Increased Funds in Research 1.3 Technological advancements in cell cultures and maintenance 1.4 Growing awareness 2. Market Restraints 2.1 Lack of infrastructural maintenance Market Segmentation: 1. Global 3D Cell Culture Market, by Application: 1.1 Drug Discovery and Toxicology Testing 1.2 Tissue Engineering and Regenerative Medicine 1.3 Cancer and Stem Cell Research 2. Global 3D Cell Culture Market, by End User: 2.1 Research Institutes 2.2 Pharmaceutical & Biotechnology Companies 3. Global 3D Cell Culture Market, by Product: 3.1 Microfluidics-Based 3D Cell Culture 3.2 Magnetic Levitation & 3D Bioprinting 3.3 Scaffold-Free 3D Cell Culture 3.3.1 Low-Adhesion Microplates 3.3.2 Hanging Drop Plates 3.3.3 3D Bioreactors 3.3.4 3D Petri Dishes 3.4 Scaffold-Based 3D Cell Culture 3.4.1 Hydrogels/ECM Analogs 3.4.2 Solid Scaffolds 3.4.3 Micropatterned Surfaces 4. Global 3D Cell Culture Market, by Region: 4.1 North America (U.S., Canada, Mexico) 4.2 Europe (Germany, UK, France, Rest of Europe) 4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 4.4 Latin America (Brazil, Argentina, Rest of Latin America) 4.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Thermo Fisher Scientific 2. Corning 3. Merck 4. Lonza 5. Reprocell 6. 3D Biotek 7. Emulate 8. Global Cell Solutions 9. Hamilton 10. Insphero 11. Kuraray 12. Mimetas 13. Nano3D Biosciences 14. Synthecon 15. Qgel These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the 3D Cell Culture Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017
Global Genomics Market By Product and Services (Instruments/Systems, Consumables, Services), Technology (Sequencing, Microarray, PCR), Process (Library Preparation, Sequencing, Data Analysis), Application (Diagnostics) and Regional Market Size, Status and Forecast to 2025

Market Overview: The global Genomics Market was valued at USD 13.2 billion in 2016 and is projected to reach USD 30.59 billion by 2025, growing at a CAGR of 9.78% from 2017 to 2025. Genomics is sequencing based technology which relies on finding out the nucleotide bases coupling and placement of DNA or genetic material of target organism or patient. The sequences are utilized in diverse ways, either in Healthcare and Pharmaceutical sector or in Gene therapy and Research Projects of evolutionary Biology. Sample Infographics: Market Dynamics: 1. Market Drivers 1.1 Increasing Growth and funds for Genomics projects 1.2 Growing demand due to less sequencing costs 1.3 Growing demands and applications of genomics in Healthcare 1.4 New company launches in Genomics sector of biotech and Bioinformatics 2. Market Restraints 2.1 High equipment cost Market Segmentation: 1. Global Genomics Market, by Technology: 1.1 Sequencing 1.2 Microarray 1.3 PCR 1.4 Nucleic Acid Extraction and Purification 1.5 Other Technologies 2. Global Genomics Market, by Products and Services: 2.1 Instruments and Systems 2.2 Consumables 2.3 Services 3. Global Genomics Market, by Application: 3.1 Diagnostics 3.1.1 Cancer Diagnostics 3.1.2 Monogenic (Mendelian) Disorders 3.1.3 Other Diagnostic Applications 3.1.3.1 Common Diseases and Complex Disorders 3.1.3.2 Movement Disorders 3.1.3.3 HIV 3.2 Drug Discovery and Development 3.3 Precision Medicine 3.4 Agriculture & Animal Research 3.5 Other Applications 4. Global Genomics Market, by Process: 4.1 Sequencing 4.2 Library Preparation 4.3 Data Analysis 5. Global Genomics Market, by End User: 5.1 Research Centers and Academic & Government Institutes 5.2 Hospitals and Clinics 5.3 Pharmaceutical & Biotechnology Companies 5.4 Other End Users 6. Global Genomics Market, by Region: 6.1 North America (U.S., Canada, Mexico) 6.2 Europe (Germany, UK, France, Rest of Europe) 6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific) 6.4 Latin America (Brazil, Argentina, Rest of Latin America) 6.5 Middle East & Africa Competitive Landscape: The major players in the market are as follows: 1. Illumina 2. Agilent Technologies 3. Thermo Fisher Scientific 4. Eurofins Scientific 5. Qiagen 6. GE Healthcare 7. F. Hoffmann-La Roche 8. Oxford Nanopore Technologies 9. Bio-Rad Laboratories 10. BGI 11. Eppendorf 12. Pacific Biosciences of California 13. Danaher These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market. Research Methodology: Research study on the Genomics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review. The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team.

2017